Back

Long COVID Study

Official Title

FLUVOXAMINE AS A TREATMENT FOR LONG COVID: A RANDOMIZED PLACEBO CONTROLLED TRIAL

Study Details

The purpose of this research study is to determine whether fluvoxamine reduces the symptoms of long COVID.

Principal Investigator

Dr. Eric Lenze

IRB Number

202211024

Eligibility

1. Participants must be 25 or older
2. Participant must self-report of past acute COVID episode within the last 3 months
3. Participants must report having trouble with memory or concentration

Volunteer Information

For more information about this study, contact Volunteer for Health at:

Back